bisindolylmaleimide i has been researched along with Endometrial Neoplasms in 1 studies
bisindolylmaleimide I: a bis(indolyl)maleimide
Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, HM | 1 |
| Schally, AV | 1 |
| Cheng, JC | 1 |
| Zarandi, M | 1 |
| Varga, J | 1 |
| Leung, PC | 1 |
1 other study available for bisindolylmaleimide i and Endometrial Neoplasms
| Article | Year |
|---|---|
Growth hormone-releasing hormone antagonist induces apoptosis of human endometrial cancer cells through PKCĪ“-mediated activation of p53/p21.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Endometrial Neopl | 2010 |